Keywords: مهارکنندههای بازجذب سروتونین; Depressive disorder, major; Treatment-resistant depression; Burden; Review; AD; Antidepressant; CBT; Cognitive behavioral therapy; CT; cognitive therapy; ECT; Electroconvulsive therapy; EQ-5D; EuroQol Five Dimension; HAM-D; Hamilton Depression Rating Scal
مقالات ISI مهارکنندههای بازجذب سروتونین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهارکنندههای بازجذب سروتونین; MeSH terms: Defibrillators; Implantable; Zolpidem; Arrhythmias; Cardiac; Electric countershock; Non-MeSH terms: phantom shock; Defibrillation; ATP; antitachycardia pacing; DFT; defibrillation threshold; EKG; electrocardiography; PS; phantom shock; ICD; im
Keywords: مهارکنندههای بازجذب سروتونین; SSRI; selective serotonin reuptake inhibitor; BMD; bone mass density; NHANES; National Health and Nutrition Examination Survey; OR; odds ratio; 5-HT; 5-hydroxytryplamine; DXA; dual-energy X-ray absorptiometry; IOM; Institute of Medicine's; RDA; recommende
Keywords: مهارکنندههای بازجذب سروتونین; EC50; concentration of a drug which induces a response halfway between the baseline and maximum after a specified exposure time; LOEC; lowest observed effect concentration; NOEC; no observed effect concentration; OECD; Organisation for Economic Co-operati
Keywords: مهارکنندههای بازجذب سروتونین; Postpartum; Stress response; Paroxetine; SSRI; Corticosterone; Estradiol;
Keywords: مهارکنندههای بازجذب سروتونین; children; adolescents; height; growth; major depressive disorder; selective serotonin reuptake inhibitors; BMI; Body mass index; GH; Growth hormone; IGF; Insulin-like growth factor; SSRI; Selective serotonin reuptake inhibitor; TORDIA; Treatment of Resist
Keywords: مهارکنندههای بازجذب سروتونین; OCD; Gabapentin; Memantine; SSRI; Fluoxetine;
Keywords: مهارکنندههای بازجذب سروتونین; Early postnatal stress; Sociability; SSRI; PTSD; Childhood maltreatment;
Keywords: مهارکنندههای بازجذب سروتونین; Depression; Meningioma; Resection; BDI; Beck Depression Inventory; HADS-D; Hospital and Anxiety Depression Scale-Depression; HRSED; Hamburg Rating Scale for Emotional Disturbances; SSRI; Selective serotonin reuptake inhibitors; WHO; World Health Organizat
Keywords: مهارکنندههای بازجذب سروتونین; AN; anorexia nervosa; ANOVA; analysis of variance; BDI-II; Beck Depression Inventory-II; BMI; body mass index; CFT-20-R; Culture Fair Test 20 Revision; EDI-2; Eating Disorder Inventory 2; HC; healthy control; IQ; intelligence quotient; MD; major depressio
Keywords: مهارکنندههای بازجذب سروتونین; BP; blood pressure; CI; confidence interval; CPT-4; Current Procedural Terminology, 4th Edition; HIPAA; Health Insurance Portability and Accountability Act; ICD-9-CM; International Classification of Diseases, 9th Revision, Clinical Modification; IOP; intr
Keywords: مهارکنندههای بازجذب سروتونین; Depression; Neuroplasticity; SSRI; Anxiety; Reproduction; Corticosteroid binding globulin;
Keywords: مهارکنندههای بازجذب سروتونین; 11βHSD; 11β-Hydroxysteroid dehydrogenase; ABC; ATP-binding cassette; AhR; aryl hydrocarbon receptor; ARNT; aryl hydrocarbon receptor nuclear translocator; BCRP; breast cancer resistance protein; CAR; constitutive androstane receptor; CYP; cytochrome P45
Keywords: مهارکنندههای بازجذب سروتونین; Hypobaric hypoxia; Altitude; Depression; Treatment-resistant depression; SSRI; Sertraline;
Keywords: مهارکنندههای بازجذب سروتونین; Epilepsy; Obsessive-compulsive disorder; Cognitive Behavioural Therapy; SSRI; Quality of life;
Keywords: مهارکنندههای بازجذب سروتونین; ACS; Acute Coronary Syndrome; CABG; Coronary Artery Bypass Graft; CI; 95% Confidence Interval; CHD; Coronary Heart Disease; BDI; Beck Depression Inventory; HAM-D; HAMilton Depression; IHD; Ischemic Heart Disease; IMT; Inspiratory Muscle Training; MD; Mean
Keywords: مهارکنندههای بازجذب سروتونین; Postpartum; Corticosterone; SSRI; Fluoxetine; Neurogenesis; Sex differences;
Keywords: مهارکنندههای بازجذب سروتونین; Ï2; chi-square; ÎS; sucrose-minus-water difference of either 1-h licking or 48-h drinking; %S; sucrose percent difference of either 1-h licking or 48-h drinking; %OAE; percent open-arm entries; %OAT; percent open-arm time; %SWIM; percent swim duration;
Keywords: مهارکنندههای بازجذب سروتونین; ADHD; Attention-deficit/hyperactivity disorder; BED; Binge-eating disorder; BOLD; Blood-oxygen-level dependent; BMI; Body mass index; BN; Bulimia nervosa; CNS; Central nervous system; DSM 5; Diagnostic and statistical manual of mental disorders, fifth edi
Keywords: مهارکنندههای بازجذب سروتونین; drug-drug interactions; psychiatric disorders; psychopharmacology; ASA; aspirin; BDI; Beck Depression Inventory; BZD; benzodiazepine; CAD; coronary artery disease; CHD; coronary heart disease; CV; cardiovascular; CVD; cardiovascular disease; CYP; cytochro
Keywords: مهارکنندههای بازجذب سروتونین; ACN; acetonitrile; AD; antidepressant; AP; antipsychotic; CAL; calibration; R2; coefficient of determination; CV; coefficient of variation; CE; collision energy; cpd; compound of interest; CI; confidence interval; dMRM; dynamic multiple reaction mode; ESI
Keywords: مهارکنندههای بازجذب سروتونین; Medial prefrontal cortex; Depression; Deep brain stimulation; Serotonin; Fluoxetine; Serotonin transporter; SSRI;
Keywords: مهارکنندههای بازجذب سروتونین; AE; adverse event; AER; adverse event rate; CAM; complementary and alternative medicine; CCMD; Chinese classification of mental disorders; CI; confidence interval; CPG; clinical practice guideline; DSM; diagnostic and statistical manual of mental disorder
Keywords: مهارکنندههای بازجذب سروتونین; Animal models of depression; SSRI; Neuropeptides; Sex; Strains;
Keywords: مهارکنندههای بازجذب سروتونین; Medial prefrontal cortex; Depression; Deep brain stimulation; Serotonin; Fluoxetine; Receptor; Serotonin transporter; SSRI;
Keywords: مهارکنندههای بازجذب سروتونین; antidepressants; blood pressure; orthostatic hypotension; SSRI;
Keywords: مهارکنندههای بازجذب سروتونین; MDD; Major Depressive Disorder; SSRI; Selective Serotonin Reuptake Inhibitor; SNRI; Serotonin Norepinephrine Reuptake Inhibitor; NRI; Norepinephrine Reuptake Inhibitor; rTMS; Repetitive Transcranial Magnetic Stimulation; Antidepressant response; Cognition
Keywords: مهارکنندههای بازجذب سروتونین; Transcranial magnetic stimulation; Neuroplasticity; Motor practice; Fluoxetine; SSRI;
Keywords: مهارکنندههای بازجذب سروتونین; PSD; post stroke depression; DSM; diagnostic and statistical manual of mental disorders; HPA; hypothalamo-pituitary-adrenal axis; DEPRESS; depression predictors after ischemic stroke; MRI; magnetic resonance imaging; CES-D; center for epidemiological stud
Keywords: مهارکنندههای بازجذب سروتونین; Depression; Antidepressants; Infant sleep; AD; Antidepressant; BISQ; Brief infant sleep questionnaire; CFI; Comparative fit index; EPDS; Edinburgh postnatal depression scale; PIBBS; Parental interactive bedtime behavior scale; RMSEA; Root mean square erro
Keywords: مهارکنندههای بازجذب سروتونین; ANCOVA; Analysis of covariance; C-CASA; Columbia Classification Algorithm for Suicide Assessment; CGI-I; Clinical Global Impressions - Global Improvement; CGI-S; Clinical Global Impressions - Severity of Illness; CRT; Choice Reaction Time; C-SSRS; Col
Keywords: مهارکنندههای بازجذب سروتونین; Capsaicin; Amitriptyline; Forced swimming test; TRPV1; Depression; Palvanil; Ami; Amitriptyline; Cap; capsaicin; CNS; central nervous system; ED50; dose required to achieve 50% of the maximal effect; EPM; elevated plus maze; FDB; flexor digitorium brevis;
Keywords: مهارکنندههای بازجذب سروتونین; USV; ultrasonic vocalization; HC; high USV/chirping/calling; LC; low USV/chirping/calling; CVS; chronic variable stress; BCAA; branched-chain amino acid; IP; intraperitoneally; HPLC; high pressure liquid chromatography; LC-MS; liquid chromatography-mass s
Keywords: مهارکنندههای بازجذب سروتونین; ALIC; anterior limb of the internal capsule; vALIC; ventral part of the anterior limb of the internal capsule; BNST; bed nucleus of the stria terminalis; CBT; cognitive behavioural therapy; DBS; deep brain stimulation; ITP; inferior thalamic peduncle; NAc
Keywords: مهارکنندههای بازجذب سروتونین; ATS; amphetamine-type stimulants; CNS; central nervous system; DFC; drug-facilitated crime; DFSA; drug-facilitated sexual assault; GABA; gamma aminobutyric acid; GHB; gamma hydroxybutyric acid; GBL; gamma butyrolactone; MDA; 3,4-methylenedioxyamphetamine;
Keywords: مهارکنندههای بازجذب سروتونین; Adolescent; Depression; fMRI; RSFC; Hypothalamic-pituitary-adrenal axis; Cortisol; Treatment response; Predictors; Antidepressants; SSRI; Personalization;
Keywords: مهارکنندههای بازجذب سروتونین; 3-MT; 3-methoxytyramine; 5-HIAA; 5-hydroxyindoleacetic acid; 5-HT; serotonin (5-hydroxytryptamine); 5-HTP; 5-hydroxy-L-tryptophan; Am; amygdala; Ap; arcopallium; Arch; archistriatum; ATD; acute tryptophan depletion; BBB; blood-brain-barrier; CL; control l
Keywords: مهارکنندههای بازجذب سروتونین; AUD; Alcohol use disorder; FDA; Food and Drug Administration; MOR; Mu opioid receptor; DOR; Delta opioid receptor; KOR; Kappa opioid receptor; NMDA; N-methyl-d-aspartate; GABA; Gaba amino butyric acid; DSM-IV; Diagnostic and statistical measurement IV; PA
Keywords: مهارکنندههای بازجذب سروتونین; 5-HT; 5-hydroxytryptamine; AA; arachidonic acid; ACh; acetylcholine; ACTH; adrenocorticotrophic hormone; AD; Alzheimer's Disease; ADP; adenosine diphosphate; Aβ; amyloid β; AMP; adenosine monophosphate; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepro
Keywords: مهارکنندههای بازجذب سروتونین; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; α-SMA; alpha- smooth muscle actin; BBB; blood-brain barrier; BDNF; brain derived neurotrophic factor; bFGF or FGF2; basic fibroblast growth factor; BrdU; bromodeoxyuridine; CIMT; const
Keywords: مهارکنندههای بازجذب سروتونین; Antidepressant; SSRI; Selective Serotonin Reuptake Inhibitor; Depression; Emotional blunting; Internet survey; Anhedonia; Apathy; Oxford Questionnaire on the Emotional Side-Effects of Antidepressants, OQESA;
Keywords: مهارکنندههای بازجذب سروتونین; BMI; body mass index; CI; confidence interval; CPRD; Clinical Practice Research Datalink; GP; general practitioner; MAOI; monoamineoxidase inhibitors; OR; odds ratio; PSC; posterior subcapsular cataract; SSRI; serotonin reuptake inhibitors; TCA; tricyclic
Keywords: مهارکنندههای بازجذب سروتونین; Venlafaxine; Withdrawal; Neonate; Abstinence; Discontinuation; Encephalopathy; SNRI; serotonin-noradrenergic reuptake inhibitor; SSRI; serotonin-selective reuptake inhibitor; EEG; Electroencephalogram;
Keywords: مهارکنندههای بازجذب سروتونین; Escitalopram; Serum concentration; Antidepressant response; SSRI; major depression; Therapeutic drug monitoring;
Keywords: مهارکنندههای بازجذب سروتونین; CVVH; Continuous venovenous haemofiltration; ECG; Electrocardiogram; ER; Emergency room; GCS; Glasgow Coma Score; IC; Intensive care; IDO; Intentional drug overdose; MC; Medium care; NSAID; Non-steroidal anti-inflammatory drug; PO2; Partial pressure of ox
Keywords: مهارکنندههای بازجذب سروتونین; ACh; Acetylcholine; cNAc; core region of the nucleus accumbens; DBS; deep brain stimulation; EGP; endogenous glucose production; NAc; nucleus accumbens; LH; lateral hypothalamic area; SSRI; shell region of the nucleus accumbens; sNAc; shell region of the
Keywords: مهارکنندههای بازجذب سروتونین; MDE; major depressive episodes; MDD; major depressive disorder; MDD-MF; major depressive disorder with mixed features; ICD-9-CM; International and Statistical Classification of Diseases, Ninth Revision, Clinical Modification; SSRI; selective serotonin reu
Keywords: مهارکنندههای بازجذب سروتونین; SSRI; Aviation safety; Alcohol; Antihistamine; Antidepressant; Depression;
Keywords: مهارکنندههای بازجذب سروتونین; aHR; adjusted hazard ratio; DDD; defined daily dose; HR; hazard ratio; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; IQR; interquartile range; LHID2000; Longitudinal Health Insurance Database 2000; NHI; Nationa
Keywords: مهارکنندههای بازجذب سروتونین; ECT; Electroconvulsive therapy; HDRS; Hamilton Depression Rating Scale-21; CGI-I; Clinical Global Impressions Improvement; IMI; imipramine; CPZ; chlorpromazine; SGA; second-generation antipsychotic; TCA; tricyclic antidepressant; SSRI; selective serotonin